Log in or Sign up for Free to view tailored content for your specialty!
Optics News
VIDEO: Myopia control effects retained after ceasing MiSight contact lens wear
DENVER – Treatment gains resulting from CooperVision’s MiSight myopia control contact lenses were found to remain in children of all ages after they switched to single vision contact lenses, according to a study presented here at ARVO.
Phacoemulsification improves vision outcomes after cataract surgery
Vision outcomes showed improvement in patients with high myopia after phacoemulsification in cataract surgery, according to a study published in Journal of Cataract and Refractive Surgery.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: One-fourth of world’s uncorrectable vision impairment due to myopia
DENVER – Twenty-nine percent of global visual impairment due to irreversible causes is attributable to myopia, Johnson & Johnson Vision’s Noel A. Brennan, MScOptom, PhD, FAAO, said here at ARVO.
VIDEO: Heru contrast sensitivity test comparable to Pelli-Robson
DENVER – Results with a contrast sensitivity application on the Heru augmented reality headset showed good agreement with the Pelli-Robson chart, according to a study presented here at ARVO.
VIDEO: Pilocarpine improves EDOF 1 hour after dosing
DENVER – Pooled phase 3 analyses showed that the use of pilocarpine 1.25% ophthalmic solution increased extended depth of focus 30% the first hour after administration, Chris Lievens, OD, of Southern College of Optometry, said at ARVO.
BLOG: Visio-vestibular testing can help predict post-concussion needs
Research into concussions has been growing rapidly over the past decade. The majority of the research that has expanded our knowledge of the signs, symptoms and clinical course of youth concussion has focused on sport-related injuries.
Digital vision demands require new approaches
In the digital age, intermediate vision is extremely important when people are using screens for as many as 12 hours a day.
VIDEO: Presbyopia treatment meets phase 2b study endpoints
WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Marjan Farid, MD, discusses the phase 2b study results of the presbyopia-correcting drop CSF-1 from Orasis.
Shamir launches new AR coating, updates progressive lens
NEW YORK – Shamir announced the launch of Glacier Expression, a premium antireflective coating, and an update to its Autograph Intelligence progressive lens design here at Vision Expo East.
Orasis reports positive results for eye drop to treat presbyopia
Orasis Pharmaceuticals announced that its phase 3 trials showed patients treated with CSF-1 achieved a statistically significant three-line or more gain in distance-corrected near visual acuity with no loss of distance visual acuity.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read